IO Biotech, Inc. — Director's Dealing 2021

Nov 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2021-11-04

Reporting Person: Glaub Kathleen Sereda (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-04	Stock Option (Right to Buy)	$14	A	21295	Acquired	2031-11-04	Common Stock (21295)	Direct

Footnotes

F1: These options vest annually over three years from the vesting commencement date of November 4, 2021, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.